ロード中...
cMET in NSCLC: Can We Cut off the Head of the Hydra? From the Pathway to the Resistance
In the last decade, the tyrosine kinase receptor cMET, together with its ligand hepatocyte growth factor (HGF), has become a target in non-small cell lung cancer (NSCLC). Signalization via cMET stimulates several oncological processes amongst which are cell motility, invasion and metastasis. It also...
保存先:
| 出版年: | Cancers (Basel) |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4491670/ https://ncbi.nlm.nih.gov/pubmed/25815459 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers7020556 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|